News: Breast Cancer

Next Page »

New target for breast cancer therapy

Monday, August 4th, 2014

by Leigh MacMillan The protein MTBP is important for growth and survival of triple negative breast cancer (TNBC) – a clinically aggressive subtype of breast cancer that is commonly resistant to targeted therapeutics – Vanderbilt investigators have discovered. Using data from The Cancer Genome Atlas, Christine Eischen, Ph.D., MSTP student Brian Grieb, Ph.D., and colleagues […]

Komen breast cancer research grants

Friday, August 1st, 2014

by Dagny Stuart Two Vanderbilt-Ingram Cancer Center investigators have received multi-year breast cancer research grants from the Susan G. Komen for the Cure Breast Cancer Foundation. Justin Balko, Ph.D., Pharm.D., research assistant professor of Medicine, won support for his research project which will use molecular profiling to prioritize adjuvant targeted therapy for triple negative breast […]

Study on breast cancer in East Asian women

Tuesday, July 29th, 2014

by Dagny Stuart A new study in East Asian women has identified three genetic changes linked to an increased risk of breast cancer. The research, led by Vanderbilt University investigators, was published online this week in Nature Genetics. While breast cancer is one of the most common malignancies among women worldwide, most studies of the […]

Abramson lands breast cancer research award

Wednesday, July 23rd, 2014

by Dagny Stuart     Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers. Abramson’s […]

Breast tissue protein may promote cancer

Friday, July 18th, 2014

by Bill Snyder A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found. Reporting recently in Nature Cell Biology, Yongliang Huo, Ph.D., and Ian Macara, Ph.D., for the first time describe the function of a protein called Par3L, which is expressed by a […]

Pietenpol joins IOM Cancer Policy Forum

Thursday, July 10th, 2014

by Dagny Stuart Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. The IOM established the forum to serve as a trusted venue for […]

Arteaga Assumes AACR Post

Tuesday, April 22nd, 2014

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center, has assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015. He was inaugurated during the AACR Annual Meeting which was held April 5-9, in San Diego. AACR, founded […]

Breast SPORE Grant Renewed Again

Wednesday, November 27th, 2013

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). The SPORE grant renewal will provide more than $11.3 million in funding support over the next five years for breast cancer research. “It is becoming uncommon for a cancer center to […]

Arteaga Leads New Cancer Initiatives

Friday, May 10th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to a leadership role of two newly created cancer research initiatives at Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer Center Research Network (VICCRN). The CCTT […]

Arteaga Named AACR President-elect

Thursday, March 28th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt University School of Medicine, has been chosen president-elect for 2013-2014 of the American Association for Cancer Research. Arteaga, who holds the Donna S. Hall Chair in Breast Cancer, also serves as associate director for clinical research and director of the Breast Cancer Research […]